These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10618282)

  • 1. Altered expression of TAP-1 and major histocompatibility complex class I in laryngeal papillomatosis: correlation of TAP-1 with disease.
    Vambutas A; Bonagura VR; Steinberg BM
    Clin Diagn Lab Immunol; 2000 Jan; 7(1):79-85. PubMed ID: 10618282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local expression of TAP-1 and MHC-I molecules and their relationship in condyloma acuminatum.
    Tao J; Zhang XP; Chen XP; Li Y; Liu YQ; Tian J; Huang CZ; Shen GX; Tu YT
    Clin Exp Dermatol; 2007 Sep; 32(5):550-5. PubMed ID: 17535281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of HLA-class I antigens in human neuroblastoma cells: analysis of its relationship to TAP and tapasin expression.
    Corrias MV; Occhino M; Croce M; De Ambrosis A; Pistillo MP; Bocca P; Pistoia V; Ferrini S
    Tissue Antigens; 2001 Feb; 57(2):110-7. PubMed ID: 11260505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the MHC class I antigen presentation machinery in human embryonal carcinomas: evidence for deficiencies in TAP, LMP and MHC class I expression and their upregulation by IFN-gamma.
    Seliger B; Dunn T; Schwenzer A; Casper J; Huber C; Schmoll HJ
    Scand J Immunol; 1997 Dec; 46(6):625-32. PubMed ID: 9420627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single-nucleotide deletion leads to rapid degradation of TAP-1 mRNA in a melanoma cell line.
    Yang T; McNally BA; Ferrone S; Liu Y; Zheng P
    J Biol Chem; 2003 Apr; 278(17):15291-6. PubMed ID: 12582163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of human papillomavirus type 11 E7 protein with TAP-1 results in the reduction of ATP-dependent peptide transport.
    Vambutas A; DeVoti J; Pinn W; Steinberg BM; Bonagura VR
    Clin Immunol; 2001 Oct; 101(1):94-9. PubMed ID: 11580231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of intracellular TAP-1 and TAP-2 in conjunction with surface MHC class I in plasma cells from patients with multiple myeloma.
    Crucian BE; Moscinski LC; Androlewicz M; Ballester OF; Widen RH; Yu H
    Br J Haematol; 1997 Aug; 98(2):426-32. PubMed ID: 9266943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular transformation of recurrent respiratory papillomatosis: viral typing and p53 overexpression.
    Go C; Schwartz MR; Donovan DT
    Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):298-302. PubMed ID: 12731623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the major histocompatibility complex class I antigen presentation machinery in normal and malignant renal cells: evidence for deficiencies associated with transformation and progression.
    Seliger B; Hohne A; Knuth A; Bernhard H; Meyer T; Tampe R; Momburg F; Huber C
    Cancer Res; 1996 Apr; 56(8):1756-60. PubMed ID: 8620489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
    Seliger B; Harders C; Lohmann S; Momburg F; Urlinger S; Tampé R; Huber C
    Eur J Immunol; 1998 Jan; 28(1):122-33. PubMed ID: 9485192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of HLA class I antigen in human papillomavirus type 16 E7 expressing HaCaT cells: correlate with TAP-1 expression.
    Li W; Deng XM; Wang CX; Zhang X; Zheng GX; Zhang J; Feng JB
    Int J Gynecol Cancer; 2010 Feb; 20(2):227-32. PubMed ID: 20134267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin.
    Delp K; Momburg F; Hilmes C; Huber C; Seliger B
    Bone Marrow Transplant; 2000 May; 25 Suppl 2():S88-95. PubMed ID: 10933198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin expression in juvenile-onset recurrent respiratory papillomatosis.
    Poetker DM; Sandler AD; Scott DL; Smith RJ; Bauman NM
    Ann Otol Rhinol Laryngol; 2002 Nov; 111(11):957-61. PubMed ID: 12450166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma.
    Vora AR; Rodgers S; Parker AJ; Start R; Rees RC; Murray AK
    Br J Cancer; 1997; 76(7):836-44. PubMed ID: 9328140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.
    Korkolopoulou P; Kaklamanis L; Pezzella F; Harris AL; Gatter KC
    Br J Cancer; 1996 Jan; 73(2):148-53. PubMed ID: 8546899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of HPV6 and downregulation of AKR1C3 expression mark malignant transformation in a patient with juvenile-onset laryngeal papillomatosis.
    Huebbers CU; Preuss SF; Kolligs J; Vent J; Stenner M; Wieland U; Silling S; Drebber U; Speel EJ; Klussmann JP
    PLoS One; 2013; 8(2):e57207. PubMed ID: 23437342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies.
    Khanna R; Burrows SR; Moss DJ; Silins SL
    J Virol; 1996 Aug; 70(8):5357-62. PubMed ID: 8764046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in laryngeal squamous cell carcinoma].
    Zeng Q; Wang XL; Xu ZG; Lü N; Zheng S; Zhao QZ; Tang PZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Mar; 47(3):234-40. PubMed ID: 22805026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA class II polymorphisms and susceptibility to recurrent respiratory papillomatosis.
    Gelder CM; Williams OM; Hart KW; Wall S; Williams G; Ingrams D; Bull P; Bunce M; Welsh K; Marshall SE; Borysiewicz L
    J Virol; 2003 Feb; 77(3):1927-39. PubMed ID: 12525627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.